As of 2025-07-17, the Relative Valuation of Korean Drug Co Ltd (014570.KQ) is 2,318.03 KRW. This relative valuation is based on P/E multiples. With the latest stock price at 4,865.00 KRW, the upside of Korean Drug Co Ltd based on Relative Valuation is -52.4%.
The range of the Relative Valuation is 586.42 - 4,508.20 KRW.
| Range | Selected | |
| Trailing P/E multiples | 14.4x - 17.1x | 16.7x |
| Forward P/E multiples | 14.3x - 18.4x | 16.2x |
| Fair Price | 586.42 - 4,508.20 | 2,318.03 |
| Upside | -87.9% - -7.3% | -52.4% |
| Date | P/E |
| 2025-07-14 | 118.15 |
| 2025-07-11 | 118.15 |
| 2025-07-10 | 117.91 |
| 2025-07-09 | 117.54 |
| 2025-07-08 | 114.71 |
| 2025-07-07 | 117.91 |
| 2025-07-04 | 117.79 |
| 2025-07-03 | 118.77 |
| 2025-07-02 | 116.80 |
| 2025-07-01 | 118.03 |
| 2025-06-30 | 118.77 |
| 2025-06-27 | 119.26 |
| 2025-06-26 | 119.51 |
| 2025-06-25 | 120.12 |
| 2025-06-24 | 120.37 |
| 2025-06-23 | 120.00 |
| 2025-06-20 | 120.74 |
| 2025-06-19 | 120.98 |
| 2025-06-18 | 121.72 |
| 2025-06-17 | 121.97 |
| 2025-06-16 | 121.60 |
| 2025-06-13 | 120.86 |
| 2025-06-12 | 122.33 |
| 2025-06-11 | 121.10 |
| 2025-06-10 | 120.61 |
| 2025-06-09 | 120.61 |
| 2025-06-05 | 120.74 |
| 2025-06-04 | 121.10 |
| 2025-06-02 | 119.75 |
| 2025-05-30 | 119.63 |
| 2025-05-29 | 120.49 |
| 2025-05-28 | 119.75 |
| 2025-05-27 | 120.12 |
| 2025-05-26 | 118.89 |
| 2025-05-23 | 120.49 |
| 2025-05-22 | 120.49 |
| 2025-05-21 | 117.91 |
| 2025-05-20 | 116.56 |
| 2025-05-19 | 116.68 |
| 2025-05-16 | 116.80 |
| 2025-05-15 | 119.26 |
| 2025-05-14 | 121.10 |
| 2025-05-13 | 120.12 |
| 2025-05-12 | 120.12 |
| 2025-05-09 | 119.01 |
| 2025-05-08 | 118.89 |
| 2025-05-07 | 118.89 |
| 2025-05-02 | 118.65 |
| 2025-04-30 | 118.52 |
| 2025-04-29 | 118.65 |